Acclarent Inc.

Patent No. 7,559,925 Issued on July 14, Assigned to Acclarent for Visualization Facilitation Device (California Inventors)
US Fed News Service, Including US State News; 7/18/2009; 447 words; ...environment. The inventors were issued U.S. Patent No. 7,559,925 on July 14. The patent has been assigned to Acclarent Inc., Menlo Park, Calif. According to the abstract released by the U.S. Patent & Trademark Office: "Devices...

Acclarent, Inc. Completes Office-Based Study Using Balloon Sinuplasty(TM) Technology.(Clinical report)
Biotech Week; 7/8/2009; 639 words; Acclarent, Inc., a leading medical technology company...hospital operating room setting (see also Acclarent, Inc.). "We are very pleased to have...our healthcare system." Keywords: Acclarent, Inc., Clinical Trial Research, Sinus...

Acclarent, Inc. Completes Office-Based Study Using Balloon Sinuplasty(TM) Technology.
PR Newswire; 6/25/2009; 564 words; ...Calif., June 25 /PRNewswire/ -- Acclarent, Inc., a leading medical technology...Harter, Chief Financial Officer of Acclarent, Inc., +1-650-687-5859 Web Site: http://www.acclarent.com/

Acclarent, Inc. Awarded 'Red Herring 100 North America'.
Health & Medicine Week; 6/8/2009; 447 words; Acclarent, Inc., a leading medical technology company...behalf of the 300 deserving employees at Acclarent, I would like to thank Red Herring...Bill Facteau, President and CEO of Acclarent, Inc. Keywords: Red Herring. This article...

Acclarent, Inc. Granted Key Patent Covering Balloon Sinuplasty(TM) Technologies.
Biotech Week; 5/20/2009; 701 words; Acclarent, Inc., the pioneer of Balloon Sinuplasty...technology assets and further differentiates Acclarent as a leader in the ENT community. The...Actions, Patents Actions, Sinusitis, Acclarent Inc. This article was prepared by Biotech...